ORIGINAL RESEARCH
Published on 12 Dec 2024
Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec’s University teaching hospitals
doi 10.3389/fonc.2024.1506172
- 512 views
- Frontiers in Genetics
- Cancer Genetics and Oncogenomics
- Research Topics
- Mechanisms of Resistance to Immunotherapy and Targeted Therapy and Predictive Biomarkers in Non-small Cell Lung Cancer
Mechanisms of Resistance to Immunotherapy and Targeted Therapy and Predictive Biomarkers in Non-small Cell Lung Cancer
1,216
Total downloads
4,504
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 20 Sep 2024
Case report: Intrapleural plus systemic Tislelizumab injection combined chemotherapy in RET gene fusion-positive lung adenocarcinoma presenting refractory malignant pleural effusion
doi 10.3389/fonc.2024.1404173
- 756 views
- 1 citation
SYSTEMATIC REVIEW
Published on 09 Jul 2024
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis
doi 10.3389/fonc.2024.1415470
- 1,229 views
ORIGINAL RESEARCH
Published on 25 Jun 2024
Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy
doi 10.3389/fonc.2024.1411436
- 759 views
Published in
Frontiers in Genetics
- Cancer Genetics and Oncogenomics
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.
Impact
- 4,504Topic views
- 2,818Article views
- 1,216Article downloads